Exon 2 was targeted with an sgRNA using CRISPR/Cas9 technology, resulting in a 49 bp deletion. Western blot and immunohistochemistry experiments confirmed the lack of peptide expression from this allele in testes. (J:307539)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count